5-α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population-based cohort study.
Henok Tadesse AyeleAntonios DourosKristian B FilionPublished in: British journal of clinical pharmacology (2022)
The use of 5αRIs was not associated with an increased risk of anaemia compared to the use of α-blockers among men with BPH.